
    
      This is an international, multicenter (up to 52 sites), randomized, single-blind study in
      patients with an acute myocardial infarction treated with the CYPHER™ (Sirolimus-eluting)
      stent as compared to the bare stents.

      Patients with de novo native coronary artery lesions will be treated with the CYPHER™
      (Sirolimus-eluting) stent or a bare stent. Subjects will be followed at 30 days, 6 months and
      at 1, 3, 4 and 5 years post-procedure. 200 subjects will have an angiographic follow-up at 8
      months.
    
  